Northwest & Ethical Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Sell
6,397
-5,063
-44% -$1.33M 0.04% 230
2026
Q1
$3.06M Buy
+11,460
New +$3.1M 0.07% 219
2018
Q4
Sell
-19,724
Closed -$2.94M 392
2018
Q3
$2.94M Sell
19,724
-698
-3% -$106K 0.18% 163
2018
Q2
$3.15M Buy
20,422
+19,108
+1,454% +$2.88M 0.21% 150
2018
Q1
$183K Buy
1,314
+116
+10% +$17K 0.01% 321
2017
Q4
$164K Buy
1,198
+466
+64% +$61.6K 0.01% 317
2017
Q3
$95K Hold
732
0.01% 344
2017
Q2
$97K Hold
732
0.01% 346
2017
Q1
$90.2K Buy
732
+116
+19% +$13.7K 0.01% 355
2016
Q4
$67.9K Buy
+616
New +$68.4K ﹤0.01% 368

Other funds holding LH

Northwest & Ethical Investments's LH Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Labcorp (LH) stake by 44% in Q2 2026, selling an estimated $1.33M and leaving 6,397 shares worth $1.79M. The position accounts for 0.04% of the portfolio, ranked #230.

Northwest & Ethical Investments first reported a position in LH in Q4 2016 and has held it in 10 quarters since. The position peaked at $3.15M in Q2 2018. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Northwest & Ethical Investments held 6,397 shares of Labcorp worth $1.79M as of Q2 2026.
  • Northwest & Ethical Investments sold 5,063 Labcorp shares in Q2 2026, an estimated $1.33M.
  • Labcorp made up 0.04% of Northwest & Ethical Investments's portfolio in Q2 2026, its #230 holding.
  • Northwest & Ethical Investments first reported a position in Labcorp in Q4 2016 and has held it in 10 quarters since.
  • Northwest & Ethical Investments's Labcorp position peaked at $3.15M in Q2 2018.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.